论文部分内容阅读
目的:观察尼莫地平治疗蛛网膜下腔出血后脑血管痉挛的临床效果,探讨其临床价值。方法:选取我院于2012年2月到2013年2月收治的76例蛛网膜下腔出血患者,将其随机分为两组,对照组38例采用常规方法治疗,观察组38例在常规治疗基础上加用尼莫地平治疗,观察治疗效果。结果:观察组的总有效率高于对照组,且再出血、脑血管痉挛、脑积水等并发症发生率低于对照组,差异比较具有统计学意义(P<0.05)。结论:蛛网膜下腔出血患者采用尼莫地平治疗可降低脑血管痉挛的发生,有效改善患者的预后效果。
Objective: To observe the clinical effect of nimodipine on cerebral vasospasm after subarachnoid hemorrhage and to explore its clinical value. Methods: Seventy-six patients with subarachnoid hemorrhage who were treated in our hospital from February 2012 to February 2013 were randomly divided into two groups. In the control group, 38 cases were treated by conventional method. In the observation group, 38 cases were treated with routine treatment Based on the use of nimodipine treatment, observe the effect of treatment. Results: The total effective rate in the observation group was higher than that in the control group. The incidences of complications such as rebleeding, cerebral vasospasm and hydrocephalus were lower than those in the control group (P <0.05). Conclusion: The treatment of nimodipine in patients with subarachnoid hemorrhage can reduce the occurrence of cerebral vasospasm and effectively improve the prognosis of patients.